Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.
The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Biotechnological Drugs market competitiveness, regional economic interdependencies, and supply chain reconfigurations.
Biotechnological Drugs Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.
Biotechnological Drugs Market by Type [Analysis by Value from 2020 to 2031]:
- Genetically Engineered Drugs
- Therapeutic Monoclonal Antibody Drugs
- Gene Therapy and Nucleic Acid Drugs
- Genetically Engineered Vaccines
- Other
Biotechnological Drugs Market by Application [Analysis by Value from 2020 to 2031]:
- Tumor
- Autoimmune Disease
- Other
Key Players in the Biotechnological Drugs Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
- 3SBIO
- Anhui Anke Biotechnology
- Beijing SL Pharmaceutical
- Biotech Pharmaceutical
- Cadila Healthcare
- Celgen Biopharma
- Celltrion
- Dr Reddy’s
- GeneScience Pharmaceuticals
- Hisun Pharma
- Jiangsu Sihuan Bioengineering
- Novartis (Sandoz)
- Pfizer (Hospira)
- Shanghai Lansheng Guojian Pharmaceutical
- Shenzhen Neptunus Interlong Bio-Technique
- Tonghua Dongbao Pharmaceutical
- Torrent Pharmaceuticals
Biotechnological Drugs Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.
Biotechnological Drugs Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.
Biotechnological Drugs Market Size & Demand Forecast (2031)
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.
Biotechnological Drugs Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.
Biotechnological Drugs Segmentation & Growth Forecasts
The study systematically breaks down the Global Biotechnological Drugs Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.
Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)
Competitive Landscape & Key Player Profiles
Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders
Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.
Why Invest in This Biotechnological Drugs Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the Biotechnological Drugs market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.
For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.
1 Market Overview
1.1 Biotechnological Drugs Definition
1.2 Global Biotechnological Drugs Market Size and Forecast
1.3 China Biotechnological Drugs Market Size and Forecast
1.4 Share of China Biotechnological Drugs Market with Respect to the Global Market
1.5 Biotechnological Drugs Market Size: China VS Global Growth Rate, 2020-2031
1.6 Biotechnological Drugs Market Dynamics
1.6.1 Biotechnological Drugs Market Drivers
1.6.2 Biotechnological Drugs Market Restraints
1.6.3 Biotechnological Drugs Industry Trends
1.6.4 Biotechnological Drugs Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Biotechnological Drugs, Global Market Share by Company, 2020-2025
2.2 Global Biotechnological Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Biotechnological Drugs Concentration Ratio
2.4 Global Biotechnological Drugs Mergers & Acquisitions, Expansion Plans
2.5 Global Biotechnological Drugs Major Companies Product Type
2.6 Head Office and Area Served of Key Players
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Biotechnological Drugs, China Market Share by Company, 2020-2025
3.2 China Biotechnological Drugs Biotechnological Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Biotechnological Drugs Industry Chain
4.2 Biotechnological Drugs Upstream Analysis
4.2.1 Biotechnological Drugs Core Raw Materials
4.2.2 Main Manufacturers of Biotechnological Drugs Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Biotechnological Drugs Production Mode
4.6 Biotechnological Drugs Procurement Model
4.7 Biotechnological Drugs Industry Sales Model and Sales Channels
4.7.1 Biotechnological Drugs Sales Model
4.7.2 Biotechnological Drugs Typical Distributors
5 Sights by Type
5.1 Biotechnological Drugs Classification
5.1.1 Genetically Engineered Drugs
5.1.2 Therapeutic Monoclonal Antibody Drugs
5.1.3 Gene Therapy and Nucleic Acid Drugs
5.1.4 Genetically Engineered Vaccines
5.1.5 Other
5.2 by Type, Global Biotechnological Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Biotechnological Drugs Consumption Value, 2020-2031
6 Sights by Application
6.1 Biotechnological Drugs Segment by Application
6.1.1 Tumor
6.1.2 Autoimmune Disease
6.1.3 Other
6.2 by Application, Global Biotechnological Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Biotechnological Drugs Consumption Value, 2020-2031
7 Sales Sights by Region
7.1 By Region, Global Biotechnological Drugs Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Biotechnological Drugs Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Biotechnological Drugs Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Biotechnological Drugs Market Size Market Share
7.4 Europe
7.4.1 Europe Biotechnological Drugs Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Biotechnological Drugs Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Biotechnological Drugs Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Biotechnological Drugs Market Size Market Share
7.6 South America
7.6.1 South AmericaBiotechnological Drugs Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Biotechnological Drugs Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Biotechnological Drugs Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Biotechnological Drugs Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Biotechnological Drugs Market Size, 2020-2031
8.3.2 by Type, United States Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Biotechnological Drugs Market Size, 2020-2031
8.4.2 by Type, Europe Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Biotechnological Drugs Market Size, 2020-2031
8.5.2 by Type, China Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Biotechnological Drugs Market Size, 2020-2031
8.6.2 by Type, Japan Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Biotechnological Drugs Market Size, 2020-2031
8.7.2 by Type, South Korea Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Biotechnological Drugs Market Size, 2020-2031
8.8.2 by Type, Southeast Asia Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Biotechnological Drugs Market Size, 2020-2031
8.9.2 by Type, India Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Biotechnological Drugs Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
9 Company Profile
9.1 3SBIO
9.1.1 3SBIO Company Information, Head Office, Market Area, and Industry Position
9.1.2 3SBIO Company Profile and Main Business
9.1.3 3SBIO Biotechnological Drugs Models, Specifications, and Application
9.1.4 3SBIO Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.1.5 3SBIO Recent Developments
9.2 Anhui Anke Biotechnology
9.2.1 Anhui Anke Biotechnology Company Information, Head Office, Market Area, and Industry Position
9.2.2 Anhui Anke Biotechnology Company Profile and Main Business
9.2.3 Anhui Anke Biotechnology Biotechnological Drugs Models, Specifications, and Application
9.2.4 Anhui Anke Biotechnology Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.2.5 Anhui Anke Biotechnology Recent Developments
9.3 Beijing SL Pharmaceutical
9.3.1 Beijing SL Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
9.3.2 Beijing SL Pharmaceutical Company Profile and Main Business
9.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
9.3.4 Beijing SL Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.3.5 Beijing SL Pharmaceutical Recent Developments
9.4 Biotech Pharmaceutical
9.4.1 Biotech Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
9.4.2 Biotech Pharmaceutical Company Profile and Main Business
9.4.3 Biotech Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
9.4.4 Biotech Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.4.5 Biotech Pharmaceutical Recent Developments
9.5 Cadila Healthcare
9.5.1 Cadila Healthcare Company Information, Head Office, Market Area, and Industry Position
9.5.2 Cadila Healthcare Company Profile and Main Business
9.5.3 Cadila Healthcare Biotechnological Drugs Models, Specifications, and Application
9.5.4 Cadila Healthcare Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.5.5 Cadila Healthcare Recent Developments
9.6 Celgen Biopharma
9.6.1 Celgen Biopharma Company Information, Head Office, Market Area, and Industry Position
9.6.2 Celgen Biopharma Company Profile and Main Business
9.6.3 Celgen Biopharma Biotechnological Drugs Models, Specifications, and Application
9.6.4 Celgen Biopharma Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.6.5 Celgen Biopharma Recent Developments
9.7 Celltrion
9.7.1 Celltrion Company Information, Head Office, Market Area, and Industry Position
9.7.2 Celltrion Company Profile and Main Business
9.7.3 Celltrion Biotechnological Drugs Models, Specifications, and Application
9.7.4 Celltrion Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.7.5 Celltrion Recent Developments
9.8 Dr Reddy’s
9.8.1 Dr Reddy’s Company Information, Head Office, Market Area, and Industry Position
9.8.2 Dr Reddy’s Company Profile and Main Business
9.8.3 Dr Reddy’s Biotechnological Drugs Models, Specifications, and Application
9.8.4 Dr Reddy’s Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.8.5 Dr Reddy’s Recent Developments
9.9 GeneScience Pharmaceuticals
9.9.1 GeneScience Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
9.9.2 GeneScience Pharmaceuticals Company Profile and Main Business
9.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Models, Specifications, and Application
9.9.4 GeneScience Pharmaceuticals Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.9.5 GeneScience Pharmaceuticals Recent Developments
9.10 Hisun Pharma
9.10.1 Hisun Pharma Company Information, Head Office, Market Area, and Industry Position
9.10.2 Hisun Pharma Company Profile and Main Business
9.10.3 Hisun Pharma Biotechnological Drugs Models, Specifications, and Application
9.10.4 Hisun Pharma Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.10.5 Hisun Pharma Recent Developments
9.11 Jiangsu Sihuan Bioengineering
9.11.1 Jiangsu Sihuan Bioengineering Company Information, Head Office, Market Area, and Industry Position
9.11.2 Jiangsu Sihuan Bioengineering Company Profile and Main Business
9.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Models, Specifications, and Application
9.11.4 Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.11.5 Jiangsu Sihuan Bioengineering Recent Developments
9.12 Novartis (Sandoz)
9.12.1 Novartis (Sandoz) Company Information, Head Office, Market Area, and Industry Position
9.12.2 Novartis (Sandoz) Company Profile and Main Business
9.12.3 Novartis (Sandoz) Biotechnological Drugs Models, Specifications, and Application
9.12.4 Novartis (Sandoz) Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.12.5 Novartis (Sandoz) Recent Developments
9.13 Pfizer (Hospira)
9.13.1 Pfizer (Hospira) Company Information, Head Office, Market Area, and Industry Position
9.13.2 Pfizer (Hospira) Company Profile and Main Business
9.13.3 Pfizer (Hospira) Biotechnological Drugs Models, Specifications, and Application
9.13.4 Pfizer (Hospira) Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.13.5 Pfizer (Hospira) Recent Developments
9.14 Shanghai Lansheng Guojian Pharmaceutical
9.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
9.14.2 Shanghai Lansheng Guojian Pharmaceutical Company Profile and Main Business
9.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
9.14.4 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
9.15 Shenzhen Neptunus Interlong Bio-Technique
9.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Information, Head Office, Market Area, and Industry Position
9.15.2 Shenzhen Neptunus Interlong Bio-Technique Company Profile and Main Business
9.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Models, Specifications, and Application
9.15.4 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
9.16 Tonghua Dongbao Pharmaceutical
9.16.1 Tonghua Dongbao Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
9.16.2 Tonghua Dongbao Pharmaceutical Company Profile and Main Business
9.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
9.16.4 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.16.5 Tonghua Dongbao Pharmaceutical Recent Developments
9.17 Torrent Pharmaceuticals
9.17.1 Torrent Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
9.17.2 Torrent Pharmaceuticals Company Profile and Main Business
9.17.3 Torrent Pharmaceuticals Biotechnological Drugs Models, Specifications, and Application
9.17.4 Torrent Pharmaceuticals Biotechnological Drugs Revenue and Gross Margin, 2020-2025
9.17.5 Torrent Pharmaceuticals Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Biotechnological Drugs Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Biotechnological Drugs Market Restraints
Table 3. Biotechnological Drugs Market Trends
Table 4. Biotechnological Drugs Industry Policy
Table 5. Global Biotechnological Drugs Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Biotechnological Drugs Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 7. Global Biotechnological Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Biotechnological Drugs Mergers & Acquisitions, Expansion Plans
Table 9. Global Biotechnological Drugs Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Biotechnological Drugs Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 12. China Biotechnological Drugs Revenue Market Share by Company, 2020-2025
Table 13. Global Key Players of Biotechnological Drugs Upstream (Raw Materials)
Table 14. Global Biotechnological Drugs Typical Customers
Table 15. Biotechnological Drugs Typical Distributors
Table 16. by Type, Global Biotechnological Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 17. by Application, Global Biotechnological Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 18. By Region, Global Biotechnological Drugs Consumption Value, 2020 VS 2024 VS 2031, US$ Million
Table 19. By Region, Global Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Table 20. By Country, Global Biotechnological Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 21. By Country, Global Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Table 22. By Country, Global Biotechnological Drugs Consumption Value Market Share, 2020-2031
Table 23. 3SBIO Company Information, Head Office, Market Area, and Industry Position
Table 24. 3SBIO Company Profile and Main Business
Table 25. 3SBIO Biotechnological Drugs Models, Specifications, and Application
Table 26. 3SBIO Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 27. 3SBIO Recent Developments
Table 28. Anhui Anke Biotechnology Company Information, Head Office, Market Area, and Industry Position
Table 29. Anhui Anke Biotechnology Company Profile and Main Business
Table 30. Anhui Anke Biotechnology Biotechnological Drugs Models, Specifications, and Application
Table 31. Anhui Anke Biotechnology Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 32. Anhui Anke Biotechnology Recent Developments
Table 33. Beijing SL Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 34. Beijing SL Pharmaceutical Company Profile and Main Business
Table 35. Beijing SL Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
Table 36. Beijing SL Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 37. Beijing SL Pharmaceutical Recent Developments
Table 38. Biotech Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 39. Biotech Pharmaceutical Company Profile and Main Business
Table 40. Biotech Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
Table 41. Biotech Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 42. Biotech Pharmaceutical Recent Developments
Table 43. Cadila Healthcare Company Information, Head Office, Market Area, and Industry Position
Table 44. Cadila Healthcare Company Profile and Main Business
Table 45. Cadila Healthcare Biotechnological Drugs Models, Specifications, and Application
Table 46. Cadila Healthcare Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 47. Cadila Healthcare Recent Developments
Table 48. Celgen Biopharma Company Information, Head Office, Market Area, and Industry Position
Table 49. Celgen Biopharma Company Profile and Main Business
Table 50. Celgen Biopharma Biotechnological Drugs Models, Specifications, and Application
Table 51. Celgen Biopharma Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 52. Celgen Biopharma Recent Developments
Table 53. Celltrion Company Information, Head Office, Market Area, and Industry Position
Table 54. Celltrion Company Profile and Main Business
Table 55. Celltrion Biotechnological Drugs Models, Specifications, and Application
Table 56. Celltrion Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 57. Celltrion Recent Developments
Table 58. Dr Reddy’s Company Information, Head Office, Market Area, and Industry Position
Table 59. Dr Reddy’s Company Profile and Main Business
Table 60. Dr Reddy’s Biotechnological Drugs Models, Specifications, and Application
Table 61. Dr Reddy’s Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 62. Dr Reddy’s Recent Developments
Table 63. GeneScience Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 64. GeneScience Pharmaceuticals Company Profile and Main Business
Table 65. GeneScience Pharmaceuticals Biotechnological Drugs Models, Specifications, and Application
Table 66. GeneScience Pharmaceuticals Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 67. GeneScience Pharmaceuticals Recent Developments
Table 68. Hisun Pharma Company Information, Head Office, Market Area, and Industry Position
Table 69. Hisun Pharma Company Profile and Main Business
Table 70. Hisun Pharma Biotechnological Drugs Models, Specifications, and Application
Table 71. Hisun Pharma Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 72. Hisun Pharma Recent Developments
Table 73. Jiangsu Sihuan Bioengineering Company Information, Head Office, Market Area, and Industry Position
Table 74. Jiangsu Sihuan Bioengineering Company Profile and Main Business
Table 75. Jiangsu Sihuan Bioengineering Biotechnological Drugs Models, Specifications, and Application
Table 76. Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 77. Jiangsu Sihuan Bioengineering Recent Developments
Table 78. Novartis (Sandoz) Company Information, Head Office, Market Area, and Industry Position
Table 79. Novartis (Sandoz) Company Profile and Main Business
Table 80. Novartis (Sandoz) Biotechnological Drugs Models, Specifications, and Application
Table 81. Novartis (Sandoz) Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 82. Novartis (Sandoz) Recent Developments
Table 83. Pfizer (Hospira) Company Information, Head Office, Market Area, and Industry Position
Table 84. Pfizer (Hospira) Company Profile and Main Business
Table 85. Pfizer (Hospira) Biotechnological Drugs Models, Specifications, and Application
Table 86. Pfizer (Hospira) Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 87. Pfizer (Hospira) Recent Developments
Table 88. Shanghai Lansheng Guojian Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 89. Shanghai Lansheng Guojian Pharmaceutical Company Profile and Main Business
Table 90. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
Table 91. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 92. Shanghai Lansheng Guojian Pharmaceutical Recent Developments
Table 93. Shenzhen Neptunus Interlong Bio-Technique Company Information, Head Office, Market Area, and Industry Position
Table 94. Shenzhen Neptunus Interlong Bio-Technique Company Profile and Main Business
Table 95. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Models, Specifications, and Application
Table 96. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 97. Shenzhen Neptunus Interlong Bio-Technique Recent Developments
Table 98. Tonghua Dongbao Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 99. Tonghua Dongbao Pharmaceutical Company Profile and Main Business
Table 100. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Models, Specifications, and Application
Table 101. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 102. Tonghua Dongbao Pharmaceutical Recent Developments
Table 103. Torrent Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 104. Torrent Pharmaceuticals Company Profile and Main Business
Table 105. Torrent Pharmaceuticals Biotechnological Drugs Models, Specifications, and Application
Table 106. Torrent Pharmaceuticals Biotechnological Drugs Revenue and Gross Margin, US$ Million, 2020-2025
Table 107. Torrent Pharmaceuticals Recent Developments
List of Figures
Figure 1. Biotechnological Drugs Picture
Figure 2. Global Biotechnological Drugs Consumption Value, (US$ million) & (2020-2031)
Figure 3. China Biotechnological Drugs Consumption Value, (US$ million) & (2020-2031)
Figure 4. By Consumption Value, China Biotechnological Drugs Market Share of Global, 2020-2031
Figure 5. Global Biotechnological Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 6. China Biotechnological Drugs Key Participants, Market Share, 2024
Figure 7. Biotechnological Drugs Industry Chain
Figure 8. Biotechnological Drugs Procurement Model
Figure 9. Biotechnological Drugs Sales Model
Figure 10. Biotechnological Drugs Sales Channels, Direct Sales, and Distribution
Figure 11. Genetically Engineered Drugs
Figure 12. Therapeutic Monoclonal Antibody Drugs
Figure 13. Gene Therapy and Nucleic Acid Drugs
Figure 14. Genetically Engineered Vaccines
Figure 15. Other
Figure 16. by Type, Global Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 17. by Type, Global Biotechnological Drugs Consumption Value Market Share, 2020-2031
Figure 18. Tumor
Figure 19. Autoimmune Disease
Figure 20. Other
Figure 21. by Application, Global Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 22. by Application, Global Biotechnological Drugs Revenue Market Share, 2020-2031
Figure 23. By Region, Global Biotechnological Drugs Consumption Value Market Share, 2020-2031
Figure 24. North America Biotechnological Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 25. By Country, North America Biotechnological Drugs Consumption Value Market Share, 2024
Figure 26. Europe Biotechnological Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 27. By Country, Europe Biotechnological Drugs Consumption Value Market Share, 2024
Figure 28. Asia Pacific Biotechnological Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 29. By Country/Region, Asia Pacific Biotechnological Drugs Consumption Value Market Share, 2024
Figure 30. South America Biotechnological Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 31. By Country, South America Biotechnological Drugs Consumption Value Market Share, 2024
Figure 32. Middle East & Africa Biotechnological Drugs Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 33. United States Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 34. by Type, United States Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 35. by Application, United States Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 36. Europe Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 37. by Type, Europe Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 38. by Application, Europe Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 39. China Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 40. by Type, China Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 41. by Application, China Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 42. Japan Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 43. by Type, Japan Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 44. by Application, Japan Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 45. South Korea Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 46. by Type, South Korea Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 47. by Application, South Korea Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 48. Southeast Asia Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 49. by Type, Southeast Asia Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 50. by Application, Southeast Asia Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 51. India Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 52. by Type, India Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 53. by Application, India Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 54. Middle East & Africa Biotechnological Drugs Consumption Value, 2020-2031, US$ Million
Figure 55. by Type, Middle East & Africa Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 56. by Application, Middle East & Africa Biotechnological Drugs Consumption Value Market Share, 2024 VS 2031
Figure 57. Research Methodology
Figure 58. Breakdown of Primary Interviews
Figure 59. Bottom-up Approaches
Figure 60. Top-down Approaches
Research Methodology:
Biotechnological Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|